Latrina Monique Williams, | |
2814 S 108th St, West Allis, WI 53227-3224 | |
(414) 885-3525 | |
Not Available |
Full Name | Latrina Monique Williams |
---|---|
Gender | Female |
Speciality | Registered Nurse - Addiction (substance Use Disorder) |
Location | 2814 S 108th St, West Allis, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043813082 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 147215-30 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Latrina Monique Williams, 2561 N 40th St, Milwaukee, WI 53210-3018 Ph: () - | Latrina Monique Williams, 2814 S 108th St, West Allis, WI 53227-3224 Ph: (414) 885-3525 |
News Archive
Researchers have proposed a three-step screening battery to identify people at risk for developing Parkinson's disease, using a combination of age, family history, hyposmia, and substantia nigra enlargement.
Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser Therapy (ILT) System. Novian developed the ILT System for the ablation of small (up to 20 mm) malignant breast tumors.
Do you always get popcorn at the movies? Or snack while you're on the couch watching television? A new paper by USC researchers reveals why bad eating habits persist even when the food we're eating doesn't taste good. The study also reveals the surprisingly simple ways we can counter our habits to gain control over what we eat.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
› Verified 7 days ago
Michelle J. Rick, R.N., NP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 8905 W Lincoln Ave, Suite 501, West Allis, WI 53227 Phone: 414-978-2229 Fax: 414-978-2279 | |
Jean Marie Dunn, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 | |
Norma Aranda, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11390 W Theodore Trecker Way, West Allis, WI 53214 Phone: 414-928-1401 | |
Antoni Vermiglio, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2054 S 102nd St Apt 331, West Allis, WI 53227 Phone: 414-702-4742 | |
Alexandra Timpe, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11390 W Theodore Trecker Way, West Allis, WI 53214 Phone: 414-928-1401 | |
Linda Chwierut, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11101 W Lincoln Ave, West Allis, WI 53227 Phone: 262-942-4000 |